KYODO NEWS IMAGELINK

報道写真の購入なら共同通信イメージリンク

お問い合わせ
03-6252-6224
平日9:30-18:00
  • 令和
  • キラリティー
  • スパコン
  • スーパーコンピューター
  • タンパク質
  • ネイチャー
  • ブラジル
  • 人間
  • 分子
  • 効果

「アジュバント」の写真・グラフィックス・映像

絞り込み
  • 提供元
  • 日付
  • 種類
  • 向き
  • カテゴリ
並び順
  • 古い順
50
( 1 50 件を表示)
  • 1
50
( 1 50 件を表示)
絞り込み
並び順
  • 古い順
  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907779

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907834

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907720

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907739

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907726

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907766

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907829

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907793

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907820

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907742

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907717

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907752

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907824

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907707

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907768

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907828

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907774

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907769

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907783

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907805

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907770

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907753

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907839

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907823

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907827

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907708

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907761

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907818

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907745

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907711

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907746

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907738

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907830

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907728

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907816

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907736

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907789

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907763

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907747

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907737

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907780

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021021907715

  • VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE
    2021年02月16日
    VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINE

    Valneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ

    商品コード: 2021030110639

  •  Brands & Logos in US - 17 Nov 2021
    2021年11月17日
    Brands & Logos in US - 17 Nov 2021

    November 17, 2021, Bothell, United States: AGC Biologics logo is seen at its corporate headquarters in Bothell. .AGC Biologics was selected by Novavax to manufacture the Matrix-M adjuvant for its COVID-19 vaccine. (Credit Image: © Toby Scott/SOPA Images via ZUMA Press Wire)、クレジット:©Toby Scott/SOPA Images via ZUMA Press Wire/共同通信イメージズ

    商品コード: 2021112001882

  •  (2)中国など3カ国の研究者、新規ワクチンアジュバントを開発
    2022年04月05日
    (2)中国など3カ国の研究者、新規ワクチンアジュバントを開発

    江南大学の胥伝来(しょ・でんらい)教授。(2021年10月29日撮影)ブラジルのスーパーコンピューター(スパコン)の力を借りて、中国、ブラジル、米国の研究者が共同で、ワクチンの潜在能力を引き出し、抗体価を約800倍高めるキラル材料を発見し、将来の抗がん剤や抗ウイルスワクチン研究に新たな考え方を提示した。研究成果はこのほど、英誌「ネイチャー」に掲載された。中国江蘇省無錫市にある江南大学食品科学・技術国家重点実験室の胥伝来(しょ・でんらい)教授によると、人間の手は完全な左右対称ではなく、キラリティーとは、その鏡像と完全に重ね合わせることができない物質の性質を指し、薬やタンパク質などの分子の機能と密接に関係している。胥氏は今回の研究により、ある種のキラル材料が新たなワクチンアジュバント(ワクチンの効果を高める補助剤)になり得ることが分かったと説明した。(無錫=新華社配信)= 配信日: 2022(令和4)年4月5日、クレジット:新華社/共同通信イメージズ

    商品コード: 2022040607174

  •  (3)中国など3カ国の研究者、新規ワクチンアジュバントを開発
    2022年04月05日
    (3)中国など3カ国の研究者、新規ワクチンアジュバントを開発

    論文の共同筆頭著者を務めた江南大学の徐麗広(じょ・れいこう)教授。(2021年10月29日撮影)ブラジルのスーパーコンピューター(スパコン)の力を借りて、中国、ブラジル、米国の研究者が共同で、ワクチンの潜在能力を引き出し、抗体価を約800倍高めるキラル材料を発見し、将来の抗がん剤や抗ウイルスワクチン研究に新たな考え方を提示した。研究成果はこのほど、英誌「ネイチャー」に掲載された。中国江蘇省無錫市にある江南大学食品科学・技術国家重点実験室の胥伝来(しょ・でんらい)教授によると、人間の手は完全な左右対称ではなく、キラリティーとは、その鏡像と完全に重ね合わせることができない物質の性質を指し、薬やタンパク質などの分子の機能と密接に関係している。胥氏は今回の研究により、ある種のキラル材料が新たなワクチンアジュバント(ワクチンの効果を高める補助剤)になり得ることが分かったと説明した。(無錫=新華社配信)= 配信日: 2022(令和4)年4月5日、クレジット:新華社/共同通信イメージズ

    商品コード: 2022040607177

  •  (1)中国など3カ国の研究者、新規ワクチンアジュバントを開発
    2022年04月05日
    (1)中国など3カ国の研究者、新規ワクチンアジュバントを開発

    江南大学食品科学・技術国家重点実験室で、研究チームの教員・学生らの実験を指導する胥伝来(しょ・でんらい)教授(中央)。(2020年10月23日撮影)ブラジルのスーパーコンピューター(スパコン)の力を借りて、中国、ブラジル、米国の研究者が共同で、ワクチンの潜在能力を引き出し、抗体価を約800倍高めるキラル材料を発見し、将来の抗がん剤や抗ウイルスワクチン研究に新たな考え方を提示した。研究成果はこのほど、英誌「ネイチャー」に掲載された。中国江蘇省無錫市にある江南大学食品科学・技術国家重点実験室の胥伝来(しょ・でんらい)教授によると、人間の手は完全な左右対称ではなく、キラリティーとは、その鏡像と完全に重ね合わせることができない物質の性質を指し、薬やタンパク質などの分子の機能と密接に関係している。胥氏は今回の研究により、ある種のキラル材料が新たなワクチンアジュバント(ワクチンの効果を高める補助剤)になり得ることが分かったと説明した。(無錫=新華社配信)= 配信日: 2022(令和4)年4月5日、クレジット:新華社/共同通信イメージズ

    商品コード: 2022040607173

  •  FDA Authorizes Updated Novavax COVID-19 Vaccine
    2023年10月03日
    FDA Authorizes Updated Novavax COVID-19 Vaccine

    October 3, 2023, Asuncion, Paraguay: Novavax logo is displayed on a smartphone backdropped by visual representation of virus, medical syringe and vials. Today, the U.S. Food and Drug Administration (FDA) amended the emergency use authorization (EUA) of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula. Individuals 12 years of age and older previously vaccinated with a COVID-19 vaccine (and who have not already been vaccinated with a recently updated mRNA COVID-19 vaccine) are eligible to receive one dose and unvaccinated individuals receive two doses. (Credit Image: © Andre M. Chang/ZUMA Press Wire)、クレジット:©Andre M. Chang/ZUMA Press Wire/共同通信イメージズ

    商品コード: 2023100412731

  •  FDA Authorizes Updated Novavax COVID-19 Vaccine
    2023年10月03日
    FDA Authorizes Updated Novavax COVID-19 Vaccine

    October 3, 2023, Asuncion, Paraguay: Novavax logo is displayed on a smartphone backdropped by visual representation of virus, medical syringe and vials. Today, the U.S. Food and Drug Administration (FDA) amended the emergency use authorization (EUA) of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula. Individuals 12 years of age and older previously vaccinated with a COVID-19 vaccine (and who have not already been vaccinated with a recently updated mRNA COVID-19 vaccine) are eligible to receive one dose and unvaccinated individuals receive two doses. (Credit Image: © Andre M. Chang/ZUMA Press Wire)、クレジット:©Andre M. Chang/ZUMA Press Wire/共同通信イメージズ

    商品コード: 2023100413253

  •  FDA Authorizes Updated Novavax COVID-19 Vaccine
    2023年10月03日
    FDA Authorizes Updated Novavax COVID-19 Vaccine

    October 3, 2023, Asuncion, Paraguay: Novavax logo is displayed on a smartphone backdropped by visual representation of virus, medical syringe and vials. Today, the U.S. Food and Drug Administration (FDA) amended the emergency use authorization (EUA) of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula. Individuals 12 years of age and older previously vaccinated with a COVID-19 vaccine (and who have not already been vaccinated with a recently updated mRNA COVID-19 vaccine) are eligible to receive one dose and unvaccinated individuals receive two doses. (Credit Image: © Andre M. Chang/ZUMA Press Wire)、クレジット:©Andre M. Chang/ZUMA Press Wire/共同通信イメージズ

    商品コード: 2023100413189

  • 1